Evercore ISI Group Reinstates Outperform on Biogen

Benzinga Newsdesk www.benzinga.com Positive 87.0%

Neg 0% Neu 0% Pos 87%

Evercore ISI Group analyst Umer Raffat reinstates Biogen (NASDAQ:BIIB) with a Outperform.

Comments

No comments yet. Be the first!